Company Directory - Pharmaco
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is an integrated specialty pharmaceutical company powered by a robust U.S. generics business and a growing branded business. Together, our team is working to build one of the most dynamic pharmaceutical companies in our rapidly changing industry.
Amphastar Pharmaceuticals, Inc., headquartered in Rancho Cucamonga, California, established in 1996, is a recognized specialty pharmaceutical company that uses state-of-the-art, cGMP compliant facilities to develop, manufacture, and market injectable, intranasal and inhalation products.
Amphista Therapeutics is a biopharmaceutical company creating first-in-class therapeutics that harness the body’s natural processes to selectively and efficiently degrade and remove disease-causing proteins. The company’s pipeline of novel targeted protein degradation (TPD) based medicines is focused on challenging diseases including cancer.
Amplia Therapeutics Limited is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. FAK is an increasingly important target in the field of cancer immunology and Amplia has a particular development focus in pancreatic and ovarian cancer.
Amring sells uniquely positioned generics that bring value to customers and patients. We spend every minute of every day figuring out how to bring historically complex prescription medications to market. Our products are generics of value to the market, not high-volume, mass-produced products.
We look beyond the ordinary, unearthing scientific potential and delivering medicines that have the potential to change the lives of people with rare, debilitating conditions. Through our in-depth knowledge and bold approach, we combine the expertise and innovation needed to help patients and their caregivers to access new treatments quickly and responsibly.
Antares Pharma is a specialty pharmaceutical company that combines drug development expertise with proprietary delivery technology to deliver safe and effective medicines. With a goal of improving dosing, reducing side effects, and improving patient compliance and outcomes, our pursuit of innovative therapies strives to positively affect patients’ lives.
Apollo Pharmaceuticals is an entrepreneurial family owned pharmaceutical company with proven expertise in the development, manufacturing and distribution of sterile injectable products. Capitalizing on our in-house R&D Lab and FDA approved QC Lab, pilot manufacturing suite and an established network of global manufacturing partners, we ensure consistent and reliable supply of customer driven products to the US market.
Founded in 1974 by Dr. Barry Sherman, we’re a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines (both generic and innovative pharmaceuticals) for patients around the world. From our humble origins of only two employees, we’ve grown to employ more than 8,000 people worldwide in manufacturing, R&D and commercial operations.
Whether large pharma or biotech, an agrochemical or animal health company, we provide you global resources and proven capabilities at every stage of the biopharma lifecycle, in small and large molecules. Our ability to offer end-to-end solutions or support standalone programs is underpinned by an innovation mindset, enabling technologies, and a partnership approach to every engagement.
Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases. Arcellx’s vision is to bring ARC-SparX platform cell therapies to millions of patients who can self-administer prescribed SparX proteins under the care of academic and community practices.
Arena Pharmaceuticals is a team with a singular focus—deliver important medicines* to patients. The global market is changing rapidly. Keeping up isn’t enough. You’ve got to stay ahead. This is the urgency that drives us day after day to understand stakeholders, to identify bold—even disruptive—ideas that will get medicines to patients.
Aristo Pharma was founded in 2008 and established itself as one of the most important pharmaceutical companies within a very short time. The company is run by management as an owner-managed medium-sized enterprise. Our product range is focused on well-known original products alongside a wide selection of the most important substances in the generics market.
Backed by the global strength of Strides and working off a strong foundation, Arrow is committed to supporting the future of Australian Retail Pharmacy and the communities they serve through its rapidly expanding portfolio of products, strategic partnerships and specialised engagement platforms.
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes.
Ascendia Pharmaceuticals specializes in the invention and development of specialty pharmaceutical products and novel formulation technologies. We provide formulation, analytical, and manufacturing services to pharmaceutical companies, working collaboratively to provide innovative solutions to challenging drug delivery problems and to create advanced medicines.
